While the effects of RPS supplementation on surrogate measures of insulin resistance, such as glucose, insulin, and GLP-1, were not captured during the randomized, double-blind, placebo-controlled trial, targeted metabolomics analyses of serum were performed to quantify circulating levels of FFAs, bile acids (BAs), and ketone bodies. This evidence concerns the gene GCG and Insulin resistance.